Skip to main content

Aberration of Nrf2‑Bach1 pathway in colorectal carcinoma; role in
carcinogenesis and tumor progression

Research Authors
Heba E.M. El-Deek, Asmaa M. Ahmed, Rabab Ahmed A. Mohammed
Research Department
Research Journal
Annals of Diagnostic Pathology
Research Publisher
NULL
Research Rank
1
Research Vol
Vol. 38
Research Website
NULL
Research Year
2019
Research_Pages
pp. 138–144
Research Abstract

Nrf2 and Bach1 are important transcriptional factors that protect against reactive oxygen species (ROS).
Although aberration of these molecules was associated with malignant transformation and progression, their
aberration pattern in colorectal carcinoma (CRC) is not yet fully studied.
In this study, Nrf2 and Bach1 were immunohistochemically examined in 93 formalin-fixed paraffin-embedded
blocks of colonic tumors (65 carcinoma with their corresponding surgical margins and 28 adenomas).
Nrf2 expression was gradually increased in the apparently normal mucosa (57 ± 41)-adenoma (90 ± 36)-
carcinoma (198 ± 78) direction and only showed significant higher mean of expression in CRC with brisk
inflammatory peritumoral response. The mean of Bach1 expression was highest in apparently normal colonic
mucosa (267 ± 16), lowest in adenoma (53 ± 31) and high in carcinoma tissues (194 ± 93). Significant
higher mean of expression was detected in carcinoma with: LN metastasis (p = 0.04), lymphovascular invasion
(p = 0.024); perineural invasion (p = 0.03) and advanced pathological stage (p < 0.001). Significant higher
mean of expression of Nrf2 and Bach1 was detected in adenoma specimens with high grade dysplasia (p = 0.016
and p = 0.024) respectively.
In conclusion, Nfr2 and Bach1 expression are altered in CRC but in different way. Nrf2 is gradually increasing
from normal mucosa to adenoma and was highest in carcinoma but was not associated with features of tumor
invasiveness. Bach1 was highest in normal mucosa; less in adenoma then increased in carcinoma and was associated with features of tumor invasiveness and metastasis. This may indicate a possible role of Nrf2 in CRC
carcinogenesis and a role of Bach1 in CRC progression.